MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
暂无分享,去创建一个
D. Kass | R. Gerszten | U. Tahir | N. Paolocci | Anna Chen | M. Ranek | C. Oeing | B. Dunkerly-Eyring | Seungho Jun | Sumita Mishra | Maria I Grajeda | Usman A. Tahir
[1] Dong I. Lee,et al. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy , 2020, Circulation research.
[2] L. Bertrand,et al. Cardiac metabolism as a driver and therapeutic target of myocardial infarction , 2020, Journal of cellular and molecular medicine.
[3] Nicola Zamboni,et al. Lipid signalling drives proteolytic rewiring of mitochondria by YME1L , 2019, Nature.
[4] J. Roose,et al. mTOR and other effector kinase signals that impact T cell function and activity , 2019, Immunological reviews.
[5] Yulin Chang,et al. Propofol can suppress renal ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signal pathway. , 2019, Gene.
[6] B. Manning,et al. Molecular logic of mTORC1 signalling as a metabolic rheostat , 2019, Nature Metabolism.
[7] Dong I. Lee,et al. Chronic Atrial and Ventricular Pacing in the Mouse: Application to Model Cardiac Dyssynchrony and Resynchronization in Heart Failure , 2019, Circulation. Heart failure.
[8] Dong Ik Lee,et al. PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress , 2018, Nature.
[9] S. Biswal,et al. S-Nitrosoglutathione Reductase Is Essential for Protecting the Female Heart From Ischemia-Reperfusion Injury , 2018, Circulation research.
[10] Hong Jiang,et al. Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury , 2018, International journal of molecular medicine.
[11] Weifeng Huang,et al. Puerarin protects rat brain against ischemia/reperfusion injury by suppressing autophagy via the AMPK-mTOR-ULK1 signaling pathway , 2018, Neural regeneration research.
[12] J. Sadoshima,et al. New Insights Into the Role of mTOR Signaling in the Cardiovascular System. , 2018, Circulation Research.
[13] Xin Ma,et al. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart , 2018, Journal of cellular and molecular medicine.
[14] D. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[15] K. Tārs,et al. Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. , 2016, The Biochemical journal.
[16] J. Inserte,et al. The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism , 2015, British journal of pharmacology.
[17] Anindita Das,et al. PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer. , 2015, Pharmacology & therapeutics.
[18] Thomas Danner,et al. Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease , 2015, Nature.
[19] Jonathan D. Powell,et al. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses , 2014, Nature Reviews Immunology.
[20] F. Sellke,et al. Rapamycin treatment of healthy pigs subjected to acute myocardial ischemia-reperfusion injury attenuates cardiac functions and increases myocardial necrosis. , 2014, The Annals of thoracic surgery.
[21] Cheng-Tien Wu,et al. Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury , 2013, PloS one.
[22] Anindita Das,et al. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. , 2012, Journal of molecular and cellular cardiology.
[23] Masaya Takahashi,et al. Cardiac mTOR protects the heart against ischemia-reperfusion injury. , 2012, American journal of physiology. Heart and circulatory physiology.
[24] Anindita Das,et al. Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection. , 2012, Journal of the American College of Cardiology.
[25] Robert A. Harris,et al. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. , 2012, Cardiovascular research.
[26] JunichiSadoshima,et al. Differential Roles of GSK-3β During Myocardial Ischemia and Ischemia/Reperfusion , 2011 .
[27] Anne E Carpenter,et al. mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.
[28] F. Vigneron,et al. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. , 2011, Cardiovascular research.
[29] A. Abbate,et al. Phosphodiesterase-5 Inhibitor, Tadalafil, Protects Against Myocardial Ischemia/Reperfusion Through Protein-Kinase G–Dependent Generation of Hydrogen Sulfide , 2009, Circulation.
[30] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[31] T. Asano,et al. Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.
[32] G. Vetrovec,et al. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. , 2006, Journal of molecular and cellular cardiology.
[33] S. Lloyd,et al. Impact of High Glucose/High Insulin and Dichloroacetate Treatment on Carbohydrate Oxidation and Functional Recovery After Low-Flow Ischemia and Reperfusion in the Isolated Perfused Rat Heart , 2005, Circulation.
[34] Steven P Gygi,et al. Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[36] F. Salloum,et al. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. , 2002, American journal of physiology. Heart and circulatory physiology.
[37] D. Yellon,et al. Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling , 2001, Circulation research.
[38] B. Griffith,et al. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. , 2000, Circulation.
[39] R. Lerch,et al. Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. , 1994, Circulation research.